ProShare Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Buy |
36,319
+4,617
| +15% | +$53.8K | ﹤0.01% | 1218 |
|
|
2025
Q1 | $236K | Sell |
31,702
-7,907
| -20% | -$58.7K | ﹤0.01% | 1573 |
|
|
2024
Q4 | $237K | Buy |
39,609
+9,009
| +29% | +$54K | ﹤0.01% | 1797 |
|
|
2024
Q3 | $157K | Buy |
30,600
+6,288
| +26% | +$32.2K | ﹤0.01% | 1791 |
|
|
2024
Q2 | $88K | Sell |
24,312
-6,265
| -20% | -$22.7K | ﹤0.01% | 1682 |
|
|
2024
Q1 | $98.2K | Buy |
30,577
+2,525
| +9% | +$8.11K | ﹤0.01% | 1822 |
|
|
2023
Q4 | $137K | Buy |
28,052
+3,838
| +16% | +$18.8K | ﹤0.01% | 1730 |
|
|
2023
Q3 | $132K | Buy |
24,214
+103
| +0.4% | +$561 | ﹤0.01% | 1578 |
|
|
2023
Q2 | $162K | Buy |
24,111
+1,060
| +5% | +$7.11K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $204K | Sell |
23,051
-3,123
| -12% | -$27.6K | ﹤0.01% | 1438 |
|
|
2022
Q4 | $200K | Buy |
26,174
+1,864
| +8% | +$14.2K | ﹤0.01% | 1504 |
|
|
2022
Q3 | $173K | Buy |
24,310
+709
| +3% | +$5.05K | ﹤0.01% | 1438 |
|
|
2022
Q2 | $192K | Buy |
23,601
+8,966
| +61% | +$72.9K | ﹤0.01% | 1484 |
|
|
2022
Q1 | $203K | Sell |
14,635
-5,239
| -26% | -$72.7K | ﹤0.01% | 1877 |
|
|
2021
Q4 | $558K | Sell |
19,874
-10,196
| -34% | -$286K | ﹤0.01% | 1371 |
|
|
2021
Q3 | $1.02M | Buy |
30,070
+4,859
| +19% | +$165K | ﹤0.01% | 900 |
|
|
2021
Q2 | $1.03M | Buy |
25,211
+5,955
| +31% | +$243K | ﹤0.01% | 1021 |
|
|
2021
Q1 | $775K | Sell |
19,256
-1,851
| -9% | -$74.5K | ﹤0.01% | 1140 |
|
|
2020
Q4 | $1.25M | Sell |
21,107
-776
| -4% | -$45.9K | ﹤0.01% | 793 |
|
|
2020
Q3 | $1.06M | Buy |
21,883
+1,609
| +8% | +$78.2K | ﹤0.01% | 708 |
|
|
2020
Q2 | $981K | Buy |
20,274
+3,137
| +18% | +$152K | 0.01% | 715 |
|
|
2020
Q1 | $476K | Sell |
17,137
-9,751
| -36% | -$271K | ﹤0.01% | 737 |
|
|
2019
Q4 | $804K | Buy |
+26,888
| New | +$804K | ﹤0.01% | 876 |
|